Legend Biotech Corporatio...
(LEGN)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Net Income | -518.25M | -445.72M | -386.21M | -307.62M | -130.37M | -1.62M | 9.37M |
Depreciation & Amortization | 20.45M | 18.39M | 13.92M | 9.93M | 5.26M | 1.68M | 217.00K |
Stock-Based Compensation | 47.68M | 34.34M | 20.16M | 4.76M | 1.27M | 704.00K | - |
Other Working Capital | 53.04M | 118.75M | 114.42M | 26.07M | 54.27M | 108.99M | 207.40M |
Other Non-Cash Items | 128.19M | 6.65M | 187.74M | 84.62M | -4.36M | -6.13M | 228.87M |
Deferred Income Tax | - | - | -174.94M | 9.22M | -7.35M | -5.66M | - |
Change in Working Capital | -71.34M | 186.32M | 140.87M | -23.92M | 52.48M | 318.71M | -16.50M |
Operating Cash Flow | -393.28M | -200.03M | -198.47M | -223.00M | -83.06M | 307.68M | -2.38M |
Capital Expenditures | -22.72M | -22.27M | -47.11M | -49.78M | -39.17M | -21.02M | -887.00K |
Acquisitions | - | - | 3.21M | 4.03M | -460.00K | 20.00K | 60.00K |
Purchase of Investments | -4.86B | -654.97M | -377.96M | -72.68M | -390.40M | -6.00M | - |
Sales Maturities Of Investments | 5.07B | 613.61M | 230.08M | 98.29M | 320.85M | - | - |
Other Investing Acitivies | -91.70M | -14.71M | -3.20M | -4.03M | 50.52M | -75.23M | 55.00K |
Investing Cash Flow | 92.79M | -78.34M | -194.98M | -24.17M | -58.65M | -102.26M | -827.00K |
Debt Repayment | -3.75M | -2.60M | -1.42M | -2.60M | -5.06M | -219.00K | -32.00K |
Common Stock Repurchased | - | - | - | - | - | - | - |
Dividend Paid | - | - | - | - | - | - | - |
Other Financial Acitivies | 211.56M | 2.93M | 4.64M | 159.40M | 19.72M | 2.72M | 3.35M |
Financial Cash Flow | 791.49M | 377.98M | 626.66M | 618.88M | 14.67M | 2.50M | 3.32M |
Net Cash Flow | 491.68M | 97.09M | 233.25M | 372.32M | -126.80M | 208.05M | 128.00K |
Free Cash Flow | -416.00M | -222.30M | -245.58M | -272.78M | -122.23M | 286.66M | -3.26M |